Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	1. tesofensine (ns 2330)	Tesofensine	-	-	-	[1]  6  💬
2	Act-293987 (ns-304)	-	-	-	-	[1] 86 💬
3	Active topical ns2 1% dermatologic cream	-	-	-	-	[1] 160 💬
4	Bardoxolone methyl, cddo-me, cddo-methyl ester, nsc 713200, chemical name: oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester	Bardoxolone	[2] D09584, D09585 💬	-	-	[1] 86 💬
5	Corticosteroid or nsaid	-	-	-	-	[1] 46 💬
6	Ips-nsc cells	-	-	-	-	[1]  6  💬
7	Non-steroidal anti-inflammatory drug (nsaid)	-	-	-	-	[1] 46 💬
8	Non-steroidal anti-inflammatory drugs (nsaids)	-	-	-	-	[1] 107 💬
9	Ns	-	-	-	-	[1]  2  💬
10	Ns 2330	-	-	-	-	[1]  6  💬
11	Ns-065/ncnp-01	-	-	-	-	[1] 113 💬
12	Ns-089/ncnp-02	-	-	-	-	[1] 113 💬
13	Ns-304	-	-	-	-	[3] 70, 86, 88 💬
14	Ns-304 placebo	-	-	-	-	[2] 70, 88 💬
15	Ns2330	-	-	-	-	[1]  6  💬
16	Nsaids	-	-	-	-	[4] 46, 70, 107, 271 💬
17	Nsaids (permitted,not necessary)	-	-	-	-	[1] 46 💬
18	Nsaids and sulfasalazine	Sulfasalazine	[1] D00448 💬	-	-	[1] 271 💬
19	Nsnsaids	-	-	-	-	[1] 271 💬
20	Nsp001	-	-	-	-	[1] 96 💬
21	Other non steroidal anti-inflammatory drugs (nsaids) except etodolac	Etodolac	[1] D00315 💬	[1] PTGS2 💬	[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	[1] 46 💬
22	Other non-selective nsaids	-	-	-	-	[1] 271 💬
23	Other: ns	-	-	-	-	[1] 96 💬
24	Patients' existing non-steroidal anti-inflammatory drug (nsaid) at approved doses	-	-	-	-	[1] 46 💬
25	Plantain nsp	-	-	-	-	[1] 96 💬
26	Recombinant human heparan nsulfatase (rhhns)	-	-	-	-	[1] 19 💬
27	Satralizumab (120 mg/pfs with nsd)	Satralizumab	[1] D11079 💬	[1] IL6R 💬	[12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	[1] 13 💬
28	Selexipag, act-293987 (ns-304)	Selexipag	[1] D09994 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬

Back to top